4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NovaBridge Biosciences (NBP) operates in the Biotechnology industry and is headquartered in Rockville, United States with about 30 employees. Its market capitalization is roughly $208 million. In the fiscal year ended 2025-12-31, NBP reported $0M in revenue and ($46M) in net income.
NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $1M | ($2M) | — |
| Gross Profit | — | — | $4M | ($36M) | $6M |
| Operating Income (EBIT) | ($94M) | ($51M) | ($49M) | ($53M) | — |
| Net Income | ($46M) | ($22M) | ($208M) | ($371M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($73M) | ($9M) | ($7M) | ($5M) | ($13M) |
| Net Income | ($31M) | ($7M) | ($6M) | ($3M) | ($9M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $260M | $213M | $369M | $590M | — |
| Total Liabilities | $30M | $12M | $126M | $169M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NBP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms